Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Application entities : Astrazeneca plc save search
Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
Published: 2024-04-02 (Crawled : 08:00) - biospace.com/
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: -1.18%
H: 0.34%
C: -0.22%
breast her2 license cancer application negative
Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer
Published: 2024-02-19 (Crawled : 09:00) - biospace.com/
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
| Email alert
Add to watchlist
lung license cancer cell application advanced
Renal Anemia Therapeutics Market Segmented by Application and Geography, Region, Size, Outlook, Share and Forecast 2022-2026 | Technavio
Published: 2022-05-18 (Crawled : 12:00) - prnewswire.com
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -2.66%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: -1.92%
H: 0.5%
C: -1.4%
AMGN | $262.75 -0.5% -0.49% 1.4M
|
Health Technology
|
| O: 0.93%
H: 0.32%
C: -1.03%
application renal anemia therapeutics market
Global Anesthetic Drugs Market (2021 to 2026) - by Drug Type, Route of Administration, Application and Geography
Published: 2022-02-18 (Crawled : 16:00) - prnewswire.com
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: -2.99%
TEVA | $12.78 -3.03% -1.8% 8.4M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.04%
ABBV | News | $164.66 0.25% -0.14% 3.6M
|
Health Technology
|
| O: -0.19%
H: 0.72%
C: -0.46%
ABT | News | $105.27 -0.6% -0.38% 5.9M
|
Health Technology
|
| O: -0.48%
H: 0.26%
C: -2.67%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: -1.02%
H: 0.43%
C: -0.84%
application drug
Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce the Initiation of Rolling Submission of a New Drug Application for CUTX-101, Copper Histidinate, for Treatment of Menkes Disease
Published: 2021-12-07 (Crawled : 13:30) - globenewswire.com
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: -2.48%
FBIO | $1.81 2.26% 2.21% 440K
|
Health Technology
|
| O: 7.0%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: -2.08%
H: 1.18%
C: 1.13%
new drug treatment application drug therapeutics disease biotech iot submission
Global $191 Billion Orphan Drugs Markets to 2026: Therapeutic Applications in Rare and Orphan Diseases, Regulatory Framework, Patents, and Innovations
Published: 2021-08-05 (Crawled : 20:00) - prnewswire.com
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: -0.85%
H: 0.15%
C: -0.16%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
ABBV | News | $164.66 0.25% -0.14% 3.6M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: -2.02%
H: 0.09%
C: -1.38%
disease drug patent application rare
Amgen Announces Tezepelumab Biologics License Application Submitted To U.S. FDA
Published: 2021-05-10 (Crawled : 16:00) - biospace.com/
BGNE | $131.96 0.08% 0.06% 110K
|
Health Technology
|
| O: -0.63%
H: 0.95%
C: -2.15%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: 1.38%
H: 0.27%
C: -0.31%
AMGN | $262.75 -0.5% -0.49% 1.4M
|
Health Technology
|
| O: 0.7%
H: 1.1%
C: -1.32%
fda license application
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
UMAC | $1.55 0.65% 16.13% 3K
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
VLD 4 | $0.2638 -3.65% 13.27% 2.6M
|
Manufacturing
TAOP | $1.08 13.01% 11.51% 19K
|
Technology Services
MGLD 4 | $1.13 5.61% 10.62% 200
|
Manufacturing
NURO | $3.65 2.24% 10.3% 3.9K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.